Forma Therapeutics logo

Forma Therapeutics

Dedicated to transforming the lives of patients with rare hematologic diseases and cancers.

159 employees · est. 2007 · Watertown, United States

VS
RiMO Therapeutics logo

RiMO Therapeutics

Enhancing cancer treatment with innovative therapy to improve patient outcomes and reduce toxicity.

est. 2015

Forma Therapeutics is the older company (2007 vs 2015).

Side-by-Side Comparison

Forma Therapeutics RiMO Therapeutics
Founded
2007 older 2015
Headquarters
Watertown, United States Not tracked yet
Employees
159 Not tracked yet
Industry
Biotechnology, Health Care, Pharmaceutical Biotechnology, Health and Wellness
Funding Stage
Series D Grant
Total Funding
$142.50M $250.00K
Funding Rounds
5 1
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Biopharmaceutical, Clinical-stage, Rare Diseases, Cancer Research, Drug Development, Oncology, Genomic Medicine, Biological Insight, Chemistry Expertise, Patient Benefit, Innovative Drug Discovery, Cancer Therapy, Oncology Drugs Oncology Drug Development, Cancer Treatment, Radiotherapy, Radiodynamic Therapy, Tumor Eradication, Non-toxic Therapies, Combination Therapies, Unmet Medical Needs, Patient Care Improvement, Checkpoint Blockade Inhibitors, Immunotherapy, University Of Chicago Research, Innovative Therapy, Toxicity Reduction, Therapeutic Modalities
Website
formatherapeutics.com rimorx.com
Forma Therapeutics logo

About Forma Therapeutics

Forma Therapeutics is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients with rare hematologic diseases and cancers. With a focus on research, development, and commercialization of novel therapeutics, the company integrates deep biology insight, chemistry expe...

RiMO Therapeutics logo

About RiMO Therapeutics

RiMO Therapeutics, Inc. (RiMO) is a biotechnology startup established in 2015 with a mission to revolutionize cancer treatment. The company's proprietary Radio-immuno Metal-Organic (RiMO) technology, developed at the University of Chicago, aims to improve patient outcomes and reduce toxicity in canc...

We will tell you when either one moves

BounceWatch watches Forma Therapeutics and RiMO Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Forma Therapeutics and RiMO Therapeutics — by email.

Frequently Asked Questions

Forma Therapeutics — Dedicated to transforming the lives of patients with rare hematologic diseases and cancers.. RiMO Therapeutics — Enhancing cancer treatment with innovative therapy to improve patient outcomes and reduce toxicity.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Forma Therapeutics has raised $142.50M while RiMO Therapeutics has raised $250.00K.
Forma Therapeutics and RiMO Therapeutics operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Forma Therapeutics with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Forma Therapeutics on 15 Sep 2024, and RiMO Therapeutics on 13 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes